Lung transplantation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) male or non-pregnant female lung transplant patients; 2) Any age; 3) first lung transplantation; 4) subjects with ideal concentration of tacrolimus treatment window and no intolerable adverse reactions; 5) those who can fully understand the purpose of the study and understand the possible adverse reactions, and who voluntarily participate in and sign the informed consent and have good compliance.
Exclusion criteria
Exclusion criteria: 1) occurrence of intolerable adverse reactions; 2) combined organ transplantation; 3) those who cannot be given tacrolimus orally; 4) accompanied with acute or chronic ulcers of the digestive system and serious gastrointestinal diseases; 5) patients receiving hemodialysis or peritoneal dialysis during the period; 6) any form of substance abuse or mental illness; 7) those with poor compliance; 8) participants in other clinical trials during the same period; 9) patients who are considered inappropriate for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trough concentrations;Liver and kidney function;body weight;CYP3A5 genotyping; | — |
Countries
China
Contacts
Wuxi People's Hospital